Preoperative administration of camrelizumab combined with chemotherapy for borderline resectable esophageal squamous cell carcinoma (BRES-1): study protocol of a single-arm, open-label, phase II study

Hang Yang, Yanan Guo, Jia Zhao, Yan Zhang, Jia Jiao, Teng Mu, Zhichao Hou, Qi Huang, Guoqing Zhang, Xiangnan Li, Jindong Li